* Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Despite many recent advances on cancer novel therapies, researchers have yet a long way to cure cancer. They have to deal with tough challenges before they can reach success. Nonetheless, it seems that recently developed immunotherapy-based therapy approaches such as adoptive cell transfer (ACT) have emerged as a promising therapeutic strategy against various kinds of tumors even the cancers in the blood (liquid cancers). The hematological (liquid) cancers are hard to be targeted by usual cancer therapies, for they do not form localized solid tumors. Until recently, two types of ACTs have been developed and introduced; tumor-infiltrating lymphocytes (TILs) and chimeric antigen receptor (CAR)-T cells which the latter is the subject of our discussion. It is interesting about engineered CAR-T cells that they are genetically endowed with unique cancer-specific characteristics, so they can use the potency of the host immune system to fight against either solid or liquid cancers. Multiple myeloma (MM) or simply referred to as myeloma is a type of hematological malignancy that affects the plasma cells. The cancerous plasma cells produce immunoglobulins (antibodies) uncontrollably which consequently damage the tissues and organs and break the immune system function. Although the last few years have seen significant progressions in the treatment of MM, still a complete remission remains unconvincing. MM is a medically challenging and stubborn disease with a disappointingly low rate of survival rate. When comparing the three most occurring blood cancers (i.e., lymphoma, leukemia, and myeloma), myeloma has the lowest 5-year survival rate (around 40%). A low survival rate indicates a high mortality rate with difficulty in treatment. Therefore, novel CAR-T cell-based therapies or combination therapies along with CAT-T cells may bring new hope for multiple myeloma patients. CAR-T cell therapy has a high potential to improve the remission success rate in patients with MM. To date, many preclinical and clinical trial studies have been conducted to investigate the ability and capacity of CAR T cells in targeting the antigens on myeloma cells. Despite the problems and obstacles, CAR-T cell experiments in MM patients revealed a robust therapeutic potential. However, several factors might be considered during CAR-T cell therapy for better response and reduced side effects. Also, incorporating the CAT-T cell method into a combinational treatment schedule may be a promising approach. In this paper, with a greater emphasis on CAR-T cell application in the treatment of MM, we will discuss and introduce CAR-T cell's history and functions, their limitations, and the solutions to defeat the limitations and different types of modifications on CAR-T cells.
=>価格を評定する, 割合, 率, 歩合, 料金, 値段, 相場, 速度, 度合, 人を〜を思う, みなす, 価値がある,
人を〜とみなす, 科金, 評価する
Overview of noun rate
The noun rate has 4 senses (first 3 from tagged texts)
1. (68) rate -- (a magnitude or frequency relative to a time unit; "they traveled at a rate of 55
miles per hour"; "the rate of change was faster than expected")
2. (39) rate, charge per unit -- (amount of a charge or payment relative to some basis; "a 10-minute
phone call at that rate would cost $5")
3. (1) pace, rate -- (the relative speed of progress or change; "he lived at a fast pace"; "he works
at a great rate"; "the pace of events accelerated")
4. rate -- (a quantity or amount or measure considered as a proportion of another quantity or amount
or measure; "the literacy rate"; "the retention rate"; "the dropout rate")
Overview of verb rate
The verb rate has 3 senses (first 3 from tagged texts)
1. (9) rate, rank, range, order, grade, place -- (assign a rank or rating to; "how would you rank
these students?"; "The restaurant is rated highly in the food guide")
2. (2) rate -- (be worthy of or have a certain rating; "This bond rates highly")
3. (1) rate, value -- (estimate the value of; "How would you rate his chances to become President?";
"Gold was rated highly among the Romans")
--- WordNet end ---